Discontinued — last reported Q4 '25
Raymond James Financial Cash, Cash Equivalents, and Marketable Securities decreased by 1.3% to $5.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.7%, from $6.67B to $5.55B. Over 2 years (FY 2020 to FY 2025), Cash, Cash Equivalents, and Marketable Securities shows a downward trend with a -11.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial health, while lower levels may signal a need for external financing.
This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term invest...
A standard liquidity metric reported by virtually all public companies on the balance sheet.
cash_equivalents_marketable_securities_total| Q2 '21 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $8.19B | $7.83B | $6.98B | $6.67B | $6.19B | $5.98B | $5.63B | $5.55B |
| QoQ Change | — | -4.5% | -10.8% | -4.5% | -7.2% | -3.3% | -5.9% | -1.3% |
| YoY Change | — | — | — | — | — | -23.6% | -19.4% | -16.7% |